Small Molecule Drug Product CDMOs

Towa International

Spain

Towa International is the international hub of Japanese generics company Towa Pharmaceutical, headquartered in Barcelona, Spain. The company researches, develops, manufactures, and distributes generic and value-added medicines worldwide, with direct presence in the US (via Breckenridge Pharmaceutical), Europe (Spain, Italy, Portugal), and 40+ countries. Towa International also operates a CMO/CDMO line, offering production capabilities to partners. It recently added a new high-containment area for potent APIs.

Tulip Lab Pvt Ltd

India

Tulip Lab Pvt Ltd is an Indian pharmaceutical manufacturing company headquartered in Mumbai. ISO 22000 certified and PIC/S certified, they manufacture allopathic and herbal products including tablets, capsules, liquids, and topicals. Their product range covers essential care, lifestyle diseases, cardiology, women's well-being, and metabolic disorders. They offer formulation development, private label, and contract manufacturing services with GMP-compliant facilities.

UI Pharmaceuticals

United States

UI Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States, operated by the University of Iowa. They offer comprehensive drug product CDMO services from formulation development through commercialization. In 2023, they launched a new 16,000 sq ft sterile processing facility with fill lines. They serve pharmaceutical, biotech, pediatrics, oncology, and research organizations worldwide.

Ultratech India Limited

India

Ultratech India Limited is an integrated Indian pharmaceutical company established in 1992, manufacturing pharmaceutical finished dosage forms, Active Pharmaceutical Ingredients, and drug intermediates. They specialize in pulmonary drug delivery systems (DPI and pMDI inhalation products) and offer Custom Research and Manufacturing Services (CRAMS) including custom synthesis, process development, private labeling, and contract manufacturing. Extensive API portfolio covers cardiovascular, antifungal, antihistamine, anti-asthmatics, antiviral, erectile dysfunction, and other therapeutic segments. WHO GMP, ISO 9001, ISO 14001 certified.

UNI-PHARMA S.A.

Greece

UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.

Unison Pharmaceuticals Private Limited

India

Unison Pharmaceuticals Private Limited is an Indian pharmaceutical company established in 1981, recognized as a Contract Manufacturing Organisation (CMO) providing quality and affordable medicines. They handle testing, production, and full packaging. The company website has minimal content but search results confirm they are a CMO supplying pharmaceutical formulations including tablets.

Upperton Pharma Solutions

United Kingdom

Upperton Pharma Solutions is a UK-based CDMO with an award-winning 60,000 sq ft development and manufacturing facility (Trent Gateway) in Nottingham. They provide integrated services from pre-clinical through late-phase manufacture for oral solids, nasal, pulmonary, and parenteral dosage forms. They recently built a new 7 million GBP sterile fill/finish manufacturing facility with MHRA submission. Services include formulation development, clinical supply manufacturing (Phase I-III), process scale-up and optimization, quality control, and analytical development and validation.

Woodstock Sterile Solutions

United States

Woodstock Sterile Solutions is a leading CDMO specializing in aseptic pharmaceutical manufacturing of sterile liquid formulations using advanced blow-fill-seal (BFS) technology. Based in Woodstock, Illinois, the company has a decades-long track record in clinical development through full-scale commercial production, with particular expertise in ophthalmic and respiratory products as well as complex solutions, suspensions, and emulsions.

Xi'an Wanlong Pharmaceutical

China

Xi'an Wanlong Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise founded in 1995, primarily producing formulations, APIs, and intermediates with GMP and DMF compliance. The Yangling facility spans 200,000 sq.m. with 18 production lines for injections, tablets, capsules, powder, and raw materials.

XL LABORATORIES PVT LTD

India

XL Laboratories Pvt Ltd is an EU GMP, PIC/s, TGA, and WHO GMP approved pharmaceutical formulations and nutraceuticals research and manufacturing company established in 2001. It holds Star Export House status from the Indian Ministry of Commerce for outstanding international market performance, with presence in 40+ countries.

YooYoung Pharmaceutical Co., Ltd.

South Korea

YooYoung Pharmaceutical Co., Ltd. is a South Korean pharmaceutical manufacturer founded in 1981. The company operates a KGMP-certified factory in Jincheon with capabilities for oral solid dosage (800 million tablets/year), ampoule injectables (25 million/year), and prefilled syringe injectables (15 million syringes/year after 2021 expansion). Offers CMO/contract manufacturing services and exports to Japan, Asia, Europe, and South America.

Zhejiang Ausun Pharmaceutical Co Ltd

China

Zhejiang Ausun Pharmaceutical Co., Ltd., established in 2010 and listed on the Shanghai Stock Exchange (2017), is a Chinese pharmaceutical company based in the Taizhou Bay Economic Development Zone, Zhejiang Province. The company specializes in R&D, production, and sale of formulations (capsules, tablets) and active pharmaceutical ingredients. They are FDA-registered (FEI 3009065969) with 3 FDA inspections (1 NAI, 2 VAI, 0 OAI), have 2 FDA-approved products (capsule and tablet, oral route), hold US DMF filings, and have participated in 1 clinical trial (Infectious Disease). They employ 1,000-4,999 people. Their website was blocked (403 WAF), so details come primarily from search results and FDA regulatory data.

Zydus Lifesciences Ltd

India

Zydus Lifesciences Ltd. (formerly Cadila Healthcare) is a major Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, ranked 4th in the Indian pharma industry with 29,000+ employees globally. In June 2025, Zydus entered the global biologics CDMO business by acquiring Agenus Inc.'s U.S. manufacturing facilities in Emeryville and Berkeley, California for $75M upfront (plus $50M milestones), now operating as independent subsidiary Zylidac Bio LLC. These facilities provide end-to-end biologics development and manufacturing from pre-clinical to commercial stages, including monoclonal antibody manufacturing for Phase-3 immuno-oncology products (Botensilimab and Balstilimab). Zydus has 15 FDA-registered facilities, 156 FDA-approved products across capsules, tablets, creams, gels, injectables (including liposomal), ointments, suppositories, and transdermal patches. They have 58 FDA inspections (25 NAI, 28 VAI, 5 OAI) and 51 recalls (2 Class I, 40 Class II, 9 Class III). Manufacturing sites span Gujarat, Maharashtra, Goa, Himachal Pradesh, Sikkim (India), plus US (Vermont, Pennsylvania, Missouri) and Brazil. Their CDMO services are specifically the biologics arm through Zylidac Bio -- the broader Zydus business is primarily own-brand generic pharmaceuticals.

Adragos Pharma

Germany

Adragos Pharma is a globally operating CDMO headquartered in Munich, Germany, specializing in small molecule finished dosage forms. They operate six manufacturing sites across Europe and Japan: Athens (Greece, HPAPI capabilities), Halden (Norway, BFS sterile production), Jura (Switzerland, small-batch clinical/commercial), Kawagoe (Japan, ampoules and tablets), Livron (France, sterile liquids and suppositories), and Leipzig (Germany, semi-solid and non-sterile liquids).

Alcami

United States

Alcami is a US-based CDMO with 45+ years of experience providing integrated drug product manufacturing, laboratory services, and cGMP pharmaceutical storage. The company specializes in sterile fill-finish manufacturing (liquid and lyophilized injectables, prefilled syringes) and oral solid dose, with DEA licensing for controlled substances and EU/Annex 1 compliance.

Altasciences

Canada

Altasciences is a North American CRO/CDMO offering integrated early-phase drug development services. The company provides preclinical safety testing, clinical pharmacology (Phase I-II), bioanalysis, and manufacturing/analytical services including formulation development, drug product manufacturing (tablets, capsules, suspensions, creams, terminally sterilized injectables), and ICH stability testing, with DEA licensing for Schedule I-V substances.

Anwita Drugs & Chemicals Pvt Ltd

India

Anwita Drugs is an Indian research-focused pharmaceutical company specializing in oral solid dosage forms (OSD), effervescent formulations, tablets, capsules, sachets, and nutraceutical supplements. They offer contract manufacturing (CRAMS) services, API & intermediate production, and finished dosage form manufacturing from their facility in Hyderabad.

Apeloa Pharmaceutical

China

Apeloa Pharmaceutical is a major Chinese CDMO and API manufacturer, publicly traded as part of the Hengdian Group, with over 7,000 employees. They are China's #2 API exporter and a top-5 Chinese CDMO. Their services span API & intermediates, CDMO, finished dosage forms, and aesthetic/care ingredients, with seven API sites and two drug product sites. They have passed 20+ US FDA inspections.

Aphena Pharma Solutions

United States

Aphena Pharma Solutions is a U.S.-based contract pharmaceutical manufacturing and packaging company operating from two FDA-registered locations. They specialize in liquid dose manufacturing, oral solid dose packaging, blister packaging, bottling, tube filling, injectable assembly, and clinical packaging. They are DEA-licensed for Schedule II-V controlled substances and ISO 13485 certified for medical devices.

Applied Laboratories, Inc.

United States

Applied Laboratories, Inc. is a cGMP contract manufacturer headquartered in Columbus, Indiana, specializing in liquids, semi-solids (creams, ointments, gels), and topical pharmaceutical products. Originally founded in 1984 as an FDA regulatory consulting firm, it evolved into a full-service contract manufacturer with 200,000 sq-ft of cGMP facilities registered for both drug and medical device production. They provide formulation development through commercial-scale manufacturing, filling, labeling, and packaging for OTC pharmaceuticals and healthcare products.

Argenta (Animal Health CRO/CDMO)

Germany

Argenta is the world's only global animal health contract research, development, and manufacturing organization (CRO/CDMO). They provide end-to-end support for veterinary medicinal products including immunologicals/vaccines, biological non-immunologicals, pharmaceuticals, and novel therapies. They offer contract manufacturing for both sterile and non-sterile animal health products, with FDA-registered facilities across multiple sites globally. Note: they serve the animal health market, not human pharmaceuticals.

Artesan Pharma

Germany

Artesan Pharma is a German full-service CDMO based in Luechow, specializing in pharmaceutical contract development and manufacturing with 501-1,000 employees. They provide services spanning formulation development to commercial manufacturing across multiple dosage forms including oral solid doses (tablets, capsules, pellets), sterile prefilled syringes with innovative production processes, and liquids. They also offer serialization, final packaging (blister), and terminal steam sterilization capabilities.

AustinPx

United States

AustinPx is a client-centric CDMO based in Georgetown, Texas, specializing in oral solid dosage formulation development and GMP manufacturing for preclinical through Phase II clinical supplies. They are the inventors of KinetiSol technology, a next-generation solvent-free amorphous solid dispersion (ASD) technology for poorly soluble APIs that offers a smaller ecological footprint and broader formulation design space compared to traditional methods like hot melt extrusion and spray drying. AustinPx provides technology-nonbiased, data-driven formulation strategies, with KinetiSol as a proprietary differentiation tool. They received the CPHI Accelerating Innovation Award and CPHI Pharma Award for Excellence in Drug Delivery Technologies in 2024.

Avara Pharmaceutical Services

United States

Avara Pharmaceutical Services is an international contract manufacturing organization (CMO) headquartered in Norman, Oklahoma, specializing in commercial-scale drug product manufacturing. Their core capabilities include oral solid dose (including potent compounds and targeted release formulations) with capacity of 1.5 billion doses per year, liquid and lyophilized sterile injectable fill-finish with terminal sterilization and high containment, and integrated packaging with serialization, automated inspection, and specialty packaging. Avara operates former branded pharmaceutical facilities in the US (Norman, Oklahoma and Arecibo, Puerto Rico) and Italy (Liscate), serving 40+ countries. Facilities hold approvals from FDA, DEA, ANVISA, MPA (Sweden), and other international agencies.

Basic Pharma

Netherlands

Basic Pharma is a full-service CDMO based in the Netherlands specializing in regulated pharmaceutical product development, manufacturing, and commercialization. They offer GMP-compliant manufacturing of medicinal products and formulations, active pharmaceutical ingredients, and analytical testing from lab scale to early clinical phase and beyond. Their state-of-the-art facility includes GMP-compliant clean rooms.

BDD Pharma

United Kingdom

BDD Pharma is a UK-based combined CDMO and CRO specializing in lean early-stage drug development. With over 25 years of experience, they provide formulation development, GMP manufacturing, and clinical testing under one roof. Their new GMP manufacturing facility in Glasgow has been approved by MHRA for investigational medicinal products (IMP) and placebo manufacturing.

Benta Lyon SAS

France

Benta Lyon SAS is a French pharmaceutical company and CDMO established nearly 50 years ago in Saint-Genis-Laval near Lyon. They specialize in the development and manufacturing of generic pharmaceutical products with GMP/BPF-certified production facilities. Their site covers 16 hectares and focuses on dry, paste, and non-sterile liquid dosage forms, with plans to add sterile injectable capabilities. Their sister company Strategie Sante provides regulatory affairs, product development, and market access support.

Bliss GVS Pharma Ltd.

India

Bliss GVS Pharma Ltd. is an Indian pharmaceutical company and the world's largest manufacturer of suppositories and pessaries, operating in 60+ international markets. The company operates six manufacturing units in Maharashtra and Daman with WHO-GMP and EU-GMP (PIC/S) approvals, producing suppositories, pessaries, tablets, dry syrups, dry powder injectables, ointments, creams, and gels. Bliss GVS offers contract manufacturing (CMO/CDMO) services alongside its own product portfolio.

Bluepharma

Portugal

Bluepharma is a Portuguese CRDMO with over 55 years of experience, offering an integrated approach from R&D through to commercial manufacturing of medicines. The company produces 2 billion units of oral solid pharmaceutical forms and has an industrial plant for high potency products. Bluepharma's facilities are EMA/Infarmed and FDA approved, and the company has expanded into advanced therapies beyond small molecules.

CD Formulation

United States

CD Formulation provides formulation development, analytical services, drug packaging, and pharmaceutical excipient solutions for pharmaceutical and biotechnology companies. The company offers contract manufacturing and contract research services including liposome cGMP manufacturing, accelerated stability studies, and a wide range of formulation types including oral solid, injectable, and topical formulations. They also supply pharmaceutical excipients and active pharmaceutical ingredients.

Cenexi

Belgium

Cenexi is a Belgian/French CDMO specializing in sterile products, biological and injectable pharmaceutical manufacturing. The company operates four manufacturing sites in Europe, including sites in Fontenay-sous-Bois and Herouville-Saint-Clair (France), Osny (France, for highly active solid pharmaceutical forms), and Belgium. Cenexi offers services from development to commercial production for pre-filled syringes, vials, lyophilized products, tablets, capsules, and syrups, with FDA-registered manufacturing operations.

Chempro Pharma

India

Chempro Pharma Pvt. Ltd. is an Indian CDMO and exporter of APIs, intermediates, KSM, impurities, pellets, and finished dosage forms (FDF). The company operates WHO/EU GMP-approved facilities and is ISO 9001 certified, with manufacturing sites in Vapi, Gujarat and Maharashtra. It provides contract manufacturing services for both APIs and finished formulations.

Coating Place Inc

United States

Coating Place Inc is a Wisconsin-based pharmaceutical CDMO founded in 1976, specializing in Wurster fluid bed coating technology for oral solid dosage forms. The company operates FDA- and EMA-approved GMP facilities in Verona and Sauk City, Wisconsin, with 24 proprietary Wurster fluid bed coaters handling batches from 0.010 kg to 800 kg, and is DEA-licensed for Schedule I-V controlled substances. The company celebrated its 50th anniversary in 2026.

Codis

United States

Codis is a global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK facility previously operated by EUROAPI, the company operates over 400,000 sq ft of cGMP manufacturing space across three sites with a 30-year regulatory track record, and is the world's leading manufacturer of Sevelamer API producing hundreds of metric tons annually.

CorePharma LLC

United States

CorePharma LLC, founded in 1998 and headquartered in Middlesex, NJ, is a CDMO specializing in oral solid dosage forms including IR and ER tablets and capsules. The company offers end-to-end services from product development and contract manufacturing to packaging and analytical testing, with cGMP-compliant FDA & DEA registered facilities producing over 2 billion units annually.

CRAMSN Research Park

India

CRAMSN Research Park is an India-based contract research, development, and manufacturing organization offering end-to-end CRO, CDMO, and CMO solutions. The company provides drug substance (API) and drug product manufacturing with multiple facilities in India and a facility in New Jersey, USA, committed to sustainable practices including green chemistry and solar-powered operations.

Crystal Pharmatech

Canada

Crystal Pharmatech is a global pharmaceutical CRO/CDMO headquartered in Canada specializing in solid-state research, advanced formulation development, and GMP manufacturing for small molecule drugs. The company offers a First-Time-Right 3-STEP approach from API form selection through crystallization development to clinical and commercial manufacturing, with sites in Canada, the US, and China.

Dalton Pharma Services

Canada

Dalton Pharma Services is a Canadian CDMO and subsidiary of Seikagaku Corporation Japan, providing integrated drug discovery, development, and manufacturing services. The company is FDA-inspected and Health Canada-approved with over 35 years of experience, specializing in custom chemical synthesis, cGMP API manufacturing, sterile vial filling, and formulation development including liposomal formulations. Dalton recently announced major expansion of its commercial sterile manufacturing capacity.

Danhson

Bulgaria

Danhson is a Bulgaria-based pharmaceutical holding company established in 2015, with group companies including Vetprom AD (65+ years of manufacturing history) and Danapha Pharmaceutical in Vietnam. The company develops, produces, and markets pharmaceutical products (Rx and OTC), food supplements, and cosmetics, with CMO/CDMO services. Danhson has invested BGN 50 million in a new production site with separate workshops for ampoule forms, liquid forms, semisolid, and biological products.

Davipharm

Vietnam

Davipharm (Dat Vi Phu Pharmaceutical JSC) is a Vietnamese pharmaceutical manufacturer and member of the Adamed group, holding EU GMP certification. The company manufactures over 300 generic drug products at its facility in Binh Duong, Vietnam, and offers CMO/CDMO services including high-potency drug manufacturing. Davipharm recently expanded its capacity and capabilities in high-potency manufacturing.

Delpharm

Canada

Delpharm is one of the world's top five CDMOs, specializing in the development and manufacture of medicines across solid, sterile, semi-solid, and liquid dosage forms with particular expertise in nasal sprays and injectables. The company operates 18 manufacturing sites and 3 development centers across Europe and North America, with 6,500 employees and over 1.1 billion EUR in turnover. Delpharm produces over 650 million units annually and recently received a $60 million Canadian government investment to modernize its Boucherville injectable facility.

DifGen Pharmaceuticals

United States

DifGen Pharmaceuticals is a US-based CDMO specializing in complex generics and advanced drug delivery systems, providing end-to-end solutions from product development through commercial manufacturing. Through its 2023 acquisition of Aveva Drug Delivery Systems Inc., DifGen gained a 455,000 sq. ft. US manufacturing footprint producing over 300 million transdermal patches annually, including controlled substances like buprenorphine transdermal systems.

Emil Pharmaceutical Industries Pvt Ltd

India

Emil Pharmaceutical Industries Pvt. Ltd. is an Indian CDMO founded in 1989, headquartered in Mumbai with three manufacturing units in MIDC Tarapur, Maharashtra. The company manufactures pharmaceuticals, nutraceuticals, and OTC formulations including tablets, capsules, powders, liquids, creams, and ointments. Emil has partnered as a CDMO with global companies including Abbott, Mylan, Pfizer, GSK, USV, and MSD, and exports to over 25 countries with certifications from WHO, ISO 9001, NAFDAC Nigeria, and FDA Ghana.

EVER Pharma

Austria

EVER Pharma is an Austrian fully integrated specialty pharmaceutical company and CDMO with over 60 years of sterile production experience, specializing in complex injectables. The company operates a state-of-the-art GMP facility in Jena, Germany producing 400+ pharmaceutical products, with particular expertise in highly active substances (narcotics, hormones, cytotoxics), crystal suspensions, and oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules.

Exela Pharma Sciences

United States

Exela Pharma Sciences is a US-based integrated specialty pharmaceutical company and CDMO founded in 2005, specializing in sterile injectable development and manufacturing. The company operates FDA-inspected cGMP facilities in Lenoir, North Carolina, with capacity to produce over 100 million sterilized units annually across liquid vials, IV bags, lyophilized vials, and pre-filled syringes.

Experic

United States

Experic is a US-based CDMO headquartered in Cranbury, NJ, specializing in pharmaceutical development, powder handling, inhalation drug products, and clinical trial supply packaging. The company has expanded its analytical laboratory capabilities and opened a facility in Dublin, Ireland to support global clinical trials.

Fisher BioServices (Thermo Fisher)

Netherlands

Fisher BioServices is part of Thermo Fisher Scientific's Patheon pharma services division, one of the world's largest CDMOs offering end-to-end 360-degree CDMO and CRO solutions. The Patheon platform covers drug substance and drug product manufacturing for small molecules, large molecules, and advanced therapies, along with clinical supply and commercialization services.

Fisiopharma

Italy

Fisiopharma is an Italian CDMO established in 1989, dedicated to the development and manufacturing of injectable pharmaceutical products in the form of liquid, suspension, and lyophilized formulations. It offers CDMO services from first product development through to commercial manufacturing at its facility in Italy.